Attorney General's Office, Maryland
Doing business as Office Of The Attorney General Prescription Drug Monitoring Program Part of State Of Maryland
- UEI
- SVSGVSKNBN11
- CAGE
- 48K70
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- FY2025 rankings
-
Its parent company, State of Maryland, ranks:
- Self-certified in SAM.gov
- Entity structure
- U.S. Government Entity
- Corporate family
-
-
Parent
State Of Maryland · Annapolis, MD
EJEEH8S7HW17
-
Parent
State Of Maryland · Annapolis, MD
EJEEH8S7HW17
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| West Virginia Attorney General | Charleston, WV | 561611 Investigation and Personal Background Check Services |
| Attorney Generals Office | Montgomery, AL | — |
| District Of Columbia Government Office Of The Inspector General | Washington, DC | — |
| Health Care Fraud | Lansing, MI | — |
| Office Of Attorney General | Tallahassee, FL | — |
About the company
Attorney General's Office, Maryland, registered with SAM.gov as a state government entity under the Prescription Drug Monitoring Program Division, serves as a prime recipient of federal grant awards from the Department of Health and Human Services Centers for Medicare and Medicaid Services. As a child entity of the State of Maryland, the organization leverages its resources to protect consumers and enforce state and federal laws related to healthcare fraud and beneficiary welfare. The office has maintained a sustained federal funding relationship focused on combating Medicaid fraud and safeguarding vulnerable populations within the state.
The Attorney General's Office, Maryland has been the prime recipient of consecutive annual formula grants under the State Medicaid Fraud Control Units program (CFDA 93.775), demonstrating consistent engagement in fraud prevention and enforcement activities. Throughout the award period from October 1, 2021 through the current fiscal year ending September 30, 2026, the organization has received formula grant funding to investigate and prosecute Medicaid provider fraud while addressing patient abuse and neglect in various settings including health facilities, board and care facilities, and non-institutional environments serving Medicaid beneficiaries. The most recent award for the period October 1, 2025 through September 30, 2026 totaled $1,779,774.00, while prior year funding in 2021-2022 reached $11,369,435.13, indicating the significant scope of the organization's fraud control operations. The Prescription Drug Monitoring Program Division operationalizes these federal grants to deliver core fraud investigation and prosecution services on behalf of the State of Maryland, working to protect Medicaid beneficiaries and state resources from fraudulent activities and ensuring accountability for those committing patient abuse or neglect.
Quick answers
Is Attorney General's Office, Maryland registered in SAM.gov?
Attorney General's Office, Maryland's SAM.gov registration expired on December 5, 2021.
How does Attorney General's Office, Maryland rank among federal contractors?
Attorney General's Office, Maryland's parent company, State of Maryland, ranked #16 in PSC J046, #22 in PSC S203 and #27 in PSC M1FD in FY2025.
What is Attorney General's Office, Maryland's most recent federal award?
Attorney General's Office, Maryland's most recent federal grant award is Medicaid fraud control unit - to investigate and prosecute medicaid provider fraud as well as patient abuse or… (2501MD5050), from Office of Management and Policy (OIG), on October 1, 2024.
On GovTribe
See Attorney General's Office, Maryland's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors